Literature DB >> 9400773

Bleb-related ocular infection in children after trabeculectomy with mitomycin C.

S Waheed1, D C Ritterband, D S Greenfield, J M Liebmann, P A Sidoti, R Ritch.   

Abstract

OBJECTIVE: The purpose of the study is to report the clinical course of bleb-related ocular infection in children after trabeculectomy with adjunctive mitomycin C.
DESIGN: The study design was a retrospective review of all patients with a diagnosis of bleb-related ocular infection after trabeculectomy with adjunctive mitomycin C. PARTICIPANTS: Three children were identified in whom late postoperative bleb-related ocular infection developed. INTERVENTION: Treatment consisted of vitreous biopsy with intravitreous antibiotic and corticosteroid injection and/or bleb culture with topical and intravenous antibiotic administration. MAIN OUTCOME MEASURES: Visual acuity and intraocular pressure were measured.
RESULTS: Bleb-related ocular infection developed an average of 16.7 +/- 10.9 months after trabeculectomy (range, 4-23 months). The mean age at presentation was 7.0 +/- 2.6 years (range, 4-10 years). Vitreous cultures were positive for staphylococci in two cases. A bleb culture from the third case also grew staphylococcus. All of the children recovered their initial vision after treatment of infection. However, one lost six lines of vision after a subsequent retinal detachment. Additional glaucoma surgery was required in one patient.
CONCLUSIONS: Late bleb-related ocular infection may occur in children after trabeculectomy with mitomycin C and is characterized by abrupt onset, bleb infiltration, and rapid progression. Despite early preservation of vision after treatment of infection, significant late visual loss can occur.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9400773     DOI: 10.1016/s0161-6420(97)30051-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  24 in total

1.  Risk factors for development of post-trabeculectomy endophthalmitis.

Authors:  O J Lehmann; C Bunce; M M Matheson; V Maurino; P T Khaw; R Wormald; K Barton
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

2.  Collagen type I and III synthesis by Tenon's capsule fibroblasts in culture: individual patient characteristics and response to mitomycin C, 5-fluorouracil, and ascorbic acid.

Authors:  R L Gross
Journal:  Trans Am Ophthalmol Soc       Date:  1999

3.  Baerveldt glaucoma implant in paediatric patients.

Authors:  K A van Overdam; J T H N de Faber; H G Lemij; P W T de Waard
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

Review 4.  Surgical interventions for primary congenital glaucoma.

Authors:  Deepta Ghate; Xue Wang
Journal:  Cochrane Database Syst Rev       Date:  2015-01-30

5.  Filtration procedures supplemented with mitomycin C in the management of childhood glaucoma.

Authors:  A Azuara-Blanco; R P Wilson; G L Spaeth; C M Schmidt; J J Augsburger
Journal:  Br J Ophthalmol       Date:  1999-02       Impact factor: 4.638

Review 6.  Childhood glaucoma surgery in the 21st century.

Authors:  M Papadopoulos; B Edmunds; C Fenerty; P T Khaw
Journal:  Eye (Lond)       Date:  2014-06-13       Impact factor: 3.775

7.  Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis).

Authors:  Preston Howard Blomquist
Journal:  Trans Am Ophthalmol Soc       Date:  2006

8.  Recurrent bleb infections.

Authors:  S Waheed; J M Liebmann; D S Greenfield; D C Ritterband; J A Seedor; M Shah; R Ritch
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

9.  Evaluation of Ahmed glaucoma valve implantation through a needle-generated scleral tunnel in Mexican children with glaucoma.

Authors:  Oscar Albis-Donado; Félix Gil-Carrasco; Rafael Romero-Quijada; Ravi Thomas
Journal:  Indian J Ophthalmol       Date:  2010 Sep-Oct       Impact factor: 1.848

10.  Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up.

Authors:  Jair Giampani; Adriana Silva Borges-Giampani; José Carlos Eudes Carani; Ernst Werner Oltrogge; Remo Susanna
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.